First Performance Period Sample Clauses

First Performance Period. If, with respect to the First Performance Period, Delta One, expressed as a percentage of the EBITDA Target for Fiscal Year 2007, equals or exceeds 33%, the Executive shall be paid a Bonus in Fiscal Year 2010 equal to one and one half (1.5) times his Base Salary for Fiscal Year 2007.
AutoNDA by SimpleDocs
First Performance Period. Notwithstanding anything to the contrary in Section 3(b), the Performance Goal shall not apply during the first Performance Period. For the avoidance of doubt, twenty-five percent (25%) of the number of Performance-Based Options shall vest on the last day of the first Performance Period, subject to (i) the Participant’s Continued Service through the last day of the first Performance Period and (ii) compliance with the terms and conditions of this Agreement (including without limitation, the restrictive covenants set forth in Appendix A).
First Performance Period. Subject to the terms and conditions of this Notice, the PRSUs covered by this Notice shall Vest on May 30, 2021 (the “Service Vesting Date”) to the extent that the performance goals described in the Statement of Performance Goals for these PRSUs for the period commencing on the Date of Grant and ending on April 20, 2021 (the “2018-2021 Performance Goals”) are achieved, once determined and certified by the Committee in its sole discretion, conditioned upon the Grantee’s continuous employment with the Company or a Subsidiary through the Service Vesting Date (the period from the Date of Grant until April 20, 2021, the “First Performance Period,” and the period from the Date of Grant until the Service Vesting Date, the “Service Vesting Period”). For purposes of this Notice, “continuously employed” (or substantially similar terms) means the absence of any interruption or termination of the Grantee’s employment with the Company or a Subsidiary. Continuous employment shall not be considered interrupted or terminated in the case of transfers between locations of the Company and its Subsidiaries.
First Performance Period. The number of Earned Units for the First Performance Period, if any, will be equal to the product of (i) one-third of the Target Number of Units (rounded to the nearest whole number) and (ii) the Performance Multiplier for the First Performance Period, provided that the maximum number of Earned Units for the First Performance Period may not exceed [___]% of one-third of the Target Number of Units.
First Performance Period. Equityholders shall be entitled to that portion of the First Tranche corresponding to the amount of Immunetrics Revenue recognized during the First Performance Period as set forth on Schedule 1 (the “First Earnout Payment”). For the avoidance of doubt, if Immunetrics Revenue is less than Five Million One Hundred Thousand Dollars ($5,100,000) during the First Performance Period (the “Floor”), the Equityholders shall not be entitled to any portion of the First Tranche and if Immunetrics Revenue equals or exceeds Six Million One Hundred Thousand Dollars ($6,100,000) during the First Performance Period (the “First Target”), Equityholders shall be entitled to the entire amount of the First Tranche. Further, if Immunetrics Revenue exceeds the First Target during the First Performance Period, such amounts in excess of the First Target shall be treated as, and therefore count towards, Immunetrics Revenue recognized during the Second Performance Period (any such excess, a “Rollover Amount”). Section 3.2

Related to First Performance Period

  • Performance Period For purposes of this Agreement, the term “Performance Period” shall be the period commencing on January 29, 2018 and ending on January 29, 2021.

  • Annual Performance Bonus In the discretion of the Company's Compensation Committee, the Executive shall be eligible to receive an annual performance bonus payable in cash for each full or partial fiscal year of the Company during the Employment Period in accordance with the Company's performance-based bonus program for Executive Officers.

  • Assist Performance Seller shall exercise its reasonable best efforts to cause to be fulfilled those conditions precedent to Buyer’s obligations to consummate the transactions contemplated hereby which are dependent upon the actions of Seller and to work with Buyer to make and/or obtain any necessary filings and consents. Seller shall cause Split-Off Subsidiary to comply with its obligations under this Agreement.

  • Performance Cycle The Performance Cycle for this Award shall commence on May 1, 2006, and shall end on December 31, 2008.

  • Performance Measure The number of Performance Shares earned at the end of the three-year Performance Period will vary depending on the degree to which cumulative adjusted earnings per share performance goals for the Performance Period, as established by the Committee, are met.

  • Measurement Period (b) In this Agreement, unless the contrary intention appears, a reference to:

  • Financial Performance Covenant Upon the occurrence and during the continuance of a Covenant Trigger Event, the Borrower will maintain a Fixed Charge Coverage Ratio of not less than 1.0 to 1.0 measured for the most recent period of four consecutive fiscal quarters for which Required Financial Statements are available (or were required to be furnished) at the time of occurrence of such Covenant Trigger Event, and each subsequent four fiscal quarter period ending during the continuance of such Covenant Trigger Event.

  • Financial Performance Covenants Notwithstanding anything to the contrary contained in Section 7.01, in the event that Holdings and the Borrower fail to comply with the requirements of any Financial Performance Covenant, until the expiration of the 10th day subsequent to the date the certificate calculating such Financial Performance Covenant is required to be delivered pursuant to Section 5.04(c), Holdings shall have the right to issue Permitted Cure Securities for cash or otherwise receive cash contributions to the capital of Holdings, and, in each case, to contribute any such cash to the capital of Borrower (collectively, the "Cure Right"), and upon the receipt by Borrower of such cash (the "Cure Amount") pursuant to the exercise by Holdings of such Cure Right such Financial Performance Covenant shall be recalculated giving effect to the following pro forma adjustments:

  • Payout In order to receive any award under this Agreement, Recipient must be employed by the Company on December 31, (the “Vesting Date”), except as provided by Sections 3.2, 3.3, 3.4, 3.5 and 4.

  • Performance Bonus If Employee's employment is terminated by Employee with cause, or by Bank without cause, Employee shall be paid, in addition to the amounts payable under Sections 3.5 and 3.6 of the Agreement: (i) all non-forfeitable deferred compensation, if any; and (ii) unpaid performance bonus payments, if any, payable under Section 4.2 of the Agreement, which shall be declared earned and payable based upon performance up to, and shall be pro-rated as of, the date of termination. Employee shall not be entitled to such unpaid performance bonus payments if Employee's employment is terminated by Bank with cause, or by Employee without cause.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!